A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways
-
By
-
Qian Yang
-
Shengyuan Yu
-
May 15, 2026
Clinical Report: Exploring the Common Genetic Foundations of Endometriosis and Migraine
Overview
This review identifies shared genetic mechanisms underlying endometriosis and migraine, emphasizing pleiotropy and common inflammatory pathways. It highlights the significance of central sensitization in exacerbating chronic pain associated with both conditions.
Background
The comorbidity of endometriosis and migraine is a significant clinical phenomenon, with affected individuals experiencing increased pain and disability. Understanding the shared biological foundations of these conditions is crucial for improving patient management and treatment strategies. This review integrates genetic epidemiology findings to propose a model that recontextualizes these disorders within a shared genetic framework.
Data Highlights
No specific numerical data provided in the article.
Key Findings
- Endometriosis and migraine share common genetic risk loci, including TRIM32 and SLC44A4.
- Mendelian Randomization analyses indicate pleiotropy rather than a causal link between the two conditions.
- Shared dysregulated biological pathways, particularly IL-1, TNF-α, and MAPK/ERK signaling, contribute to both disorders.
- Central sensitization is a significant factor linking endometriosis and migraine, worsening chronic pain.
- The proposed model suggests potential for genetic stratification and repurposing treatments targeting common inflammatory pathways.
Clinical Implications
Clinicians should consider the genetic and inflammatory connections between endometriosis and migraine when diagnosing and treating patients. Early recognition of endometriosis may facilitate screening for coexisting migraine, leading to more effective management strategies.
Conclusion
This review underscores the importance of understanding the shared genetic foundations of endometriosis and migraine, paving the way for personalized treatment approaches in affected patients.
Related Resources & Content
- Brain, 2023 -- Composite microRNA–genetic risk score model links to migraine and implicates its pathogenesis
- Frontiers in Reproductive Health, 2026 -- Multi-omics Mendelian randomization identifies mitochondrial genes associated with immune microenvironment signatures in endometriosis
- BMC Psychiatry, 2025 -- Mechanisms of Comorbidity and Neuroimmune Dysregulation in Major Depressive Disorder and Migraine
- Brain, 2023 -- Diagnosing migraine from genome-wide genotype data: a machine learning analysis
- ACOG Endometriosis Guidelines Target Diagnostic Delays | JAMA | JAMA Network, 2026
- BMC Women's Health, 2026 -- Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial
- Nature Genetics, 2026 -- Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations
- ACOG Endometriosis Guidelines Target Diagnostic Delays | JAMA | JAMA Network
- Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial | BMC Women's Health | Springer Nature Link
- Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations | Nature Genetics
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.